FDA uncovers new quality-control problems at Lilly’s factory
The FDA inspectors discovered that Lilly’s employees had not properly tracked contaminated drugs batches that were supposed to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Oct 22
The FDA inspectors discovered that Lilly’s employees had not properly tracked contaminated drugs batches that were supposed to…
11 Oct 22
The drug is indicated for congestion due to fluid overload in adults with New York Heart Association Class…
10 Oct 22
Boostrix was previously approved to prevent tetanus, diphtheria and whooping cough in children aged 10 years and above,…
30 Sep 22
Relyvrio, previously known as AMX0035 in the US, is an oral, fixed-dose combination therapy intended for the treatment…
29 Sep 22
The FDA approval of Dupixent is based on data from two Phase 3 PRIME and PRIME2 clinical trials,…
26 Sep 22
The EC approval follows a positive opinion granted by the European Medicines Agency (EMA)’s Committee for Medicinal Products…
22 Sep 22
Retevmo is an oral, selective RET kinase inhibitor, indicated for locally advanced or metastatic solid tumours with a…
20 Sep 22
The EC approval of Vabysmo is supported by positive results from four Phase 3 studies, including TENAYA and…
16 Sep 22
According to the competition watchdog, Novartis allegedly misused its patent rights to reduce competitive pressure on its skin…
08 Sep 22
The company’s investigational vaccine candidate is indicated for the prevention of invasive GBS disease in newborns and young…